Professor Ramon Andrade De Mello

Professor Ramon Andrade De Mello is a prominent board-certified consultant medical oncologist based in London who specialises in the diagnosis and treatment of bile duct cancer (cholangiocarcinoma) and biliary cancer, alongside pancreatic cancer, cancer of unknown primary, and gastric cancer.

As an expert in precision medicine, Professor De Mello provides cancer care that is tailored to each patient’s needs and that includes the use of targeted therapies, infusion and oral chemotherapy, and hepatic lesions such as radio-ablation/chemoembolization. Alongside his NHS work at Oxford University Hospitals, Professor De Mello currently sees patients at Harley Street.

Professor De Mello is highly qualified. He has an MD from the Federal University of Ceara, Brazil and both a PG Diploma and a PhD in Medicine and Molecular Oncology from the University of Porto, Portugal. Professor De Mello undertook his medical oncology training at the cancer hospital, Oncology Institute Francisco Gentil, with the support from Portugal’s Central Administration of the Health System, and also completed an internship in general medicine. In the UK, he was awarded three prestigious fellowships: a fellowship in immunotherapy, a fellowship in general ultrasound, and a clinical research fellowship in lung cancer clinical trials at the Royal Marsden NHS Foundation Trust.

Currently, Professor De Mello is a senior consultant medical oncologist for upper gastrointestinal and breast cancer at the Churchill Hospital at the Oxford Cancer Centre as well as an honorary senior clinical researcher at the renowned University of Oxford. Furthermore, since 2018, he also serves as professor, research supervisor and the chief of the medical oncology discipline at Nine of July University, where he is the director for the precision oncology and health economics research group.

With an extensive background in clinical research, Professor De Mello has participated in more than 40 industry supported and academic phase II-III clinical trials in biomarkers and immunotherapy for cancer as principal and sub-investigator. Professor De Mello is a fellow of the American College of Physicians and a member of various professional organisations, including the European Society for Medical Oncology. Throughout his illustrious trajectory, he has authored numerous publications, abstracts and book chapters in peer-reviewed journals, and as a respected figure in his field, Professor De Mello has also been invited to speak at select congresses around the world, most notably the United International Oncology Congress.

*Professor De Mello also provides online prescriptions.